Psoriasis is a chronic T-lymphocyte-mediated inflammatory disorder that affects 2-3% of the population globally. It is associated with abnormal keratinocyte proliferation, and is clinically characterized by erythematous, clearly demarcated papules and rounded plaques. Approximately 75% of patients with ...
The pipeline and market for psoriasis drugs Rami Al-Horani Thomas Chui Bashar Hamad From the Analyst's Couch31 Jan 2024 Biopharma dealmaking in 2023 Patricia Giglio Amanda Micklus From the Analyst's Couch16 Jan 2024 The landscape and market for HIV therapies Zachery G. Bowe Shiva ...
Discover essential insights and analysis for the pharmaceutical industry with Scrip. Stay updated on trends, innovations, and market intelligence.
We are confident that, as these and our phase I pipeline move through development, we will build the best late stage pharmaceutical pipeline in the industry. We plan to provide a detailed update on progress in R&D towards the end of 2003. Success as partner of choice The size and quality ...
and aims to treatpsoriasis, as well as an innovative pipeline of oral peptide candidates targeting various autoimmune diseases. Additionally, AbbVie will gain access to Nimble's peptide synthesis, screening, and optimization platform, which employs proprietary technology to accelerate the discovery and ...
2025 January 17, 2025 Aragen $100m PE boost to bolster CDMO ambition in India and beyond Let's begin the conversation. By submitting this form you agree to ourPrivacy Policyconcerning the way Aragen may use your personal information.
Additionally, there is a booming biosimilar research and development pipeline in China. However, unlike European countries, which have established and implemented comprehensive policies to promote the uptake of biosimilars, including financial incentives created by pricing, reimbursement, and provider payment...
dollars for bringing the new drug to the market. Researchers identify particular cellular and genetic factors that play a major role in each disease condition [2]. They target these biological markers with newly developed biological and chemical agents. Sometimes the developed molecules show drug-...
Additionally, there is a booming biosimilar research and development pipeline in China. However, unlike European countries, which have established and implemented comprehensive policies to promote the uptake of biosimilars, including financial incentives created by pricing, reimbursement, and provider payment...
The kallikrein-kinin system is a key regulatory cascade involved in blood pressure maintenance, hemostasis, inflammation and renal function. Currently, approved drugs remain limited to the rare disease hereditary angioedema. However, growing interest in